BaltMed - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,468,569 | 1,736,709 | 1,810,270 | 2,252,988 | 2,328,775 | 2,485,025 | 1,882,484 | 1,937,286 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 10,670 | 32,498 | 150,409 | 197,313 | 86,477 | 76,360 | -48,045 | 15,904 |
| Equity | 319,329 | 351,827 | 502,236 | 699,549 | 786,026 | 862,386 | 814,341 | 830,245 |
| Liabilities | 139,449 | 287,524 | 245,171 | 142,063 | 120,808 | 218,627 | 416,503 | 260,712 |
| Non-current assets | 18,017 | 12,445 | 10,280 | 9,253 | 12,083 | 62,003 | 48,969 | 44,854 |
| Current assets | 452,001 | 602,807 | 759,461 | 1,000,743 | 1,081,303 | 1,032,780 | 1,160,593 | 1,081,374 |
| Total assets | 470,018 | 615,252 | 769,741 | 1,009,996 | 1,093,386 | 1,094,783 | 1,209,562 | 1,126,228 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 402,362 | 336,606 | 317,340 |
| Social insurance contributions | - | - | - | - | - | 61,798 | 68,391 | 62,394 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -5.2% | +18.3% | +4.2% | +24.5% | +3.4% | +6.7% | -24.2% | +2.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.3% | 5.3% | 19.5% | 19.5% | 7.9% | 7.0% | -4.0% | 1.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 3.3% | 9.2% | 29.9% | 28.2% | 11.0% | 8.9% | -5.9% | 1.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.7% | 1.9% | 8.3% | 8.8% | 3.7% | 3.1% | -2.6% | 0.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.8 | 0.5 | 0.2 | 0.2 | 0.3 | 0.5 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 183,571 | 217,089 | 226,284 | 281,624 | 291,097 | 310,628 | 235,311 | 273,500 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BaltMed - Social security debts
The amount of overdue SODRA debt for the company BaltMed as of the last working day is: 0 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 0.10 |
| 2026-08-26 | 2026-09-02 | 0.10 |
| 2026-08-23 | 2026-08-23 | 0.10 |
| 2026-08-19 | 2026-08-19 | 0.10 |
BaltMed - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-01 | 2026-04-24 | 5.53 |
| 2025-05-01 | 2025-05-08 | 1.55 |
| 2025-04-30 | 2025-04-30 | 0.7 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BaltMed, UAB (code 302582602) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €1.94M and net profit of €15.9K, corresponding to a profit margin of 0.8%. Results improved from 2024, when revenue was €1.88M and the company posted a net loss of €48.0K, while still remaining below the 2023 level of €2.49M revenue and €76.4K net profit. Over the two-year period, revenue declined by 22.0%, but 2025 showed a modest recovery with 2.9% year-on-year growth. The balance sheet remained solid in 2025, with total assets of €1.13M, equity of €830.2K and liabilities of €260.7K. Key ratios point to a relatively strong capital structure, including an equity ratio of 73.7% and debt-to-equity of 0.31. Asset turnover stood at 1.72x, while revenue per employee reached €276.8K and profit per employee was €2.3K.